EXPANDED PROGRAM OF IMMUNIZATION VACCINE PRICES FOR ...
Recommend Documents
vaccinated children at school level indication of natural infection and .... WCJ, Gerards LJ, et al. ... [36] Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST,.
May 17, 2014 - Background: Immunization averts an estimated 2 to 3 million deaths ... town and Arba Minch Zuria district, Southern Ethiopia in March 2013.
Comprehensive multi-year Plan | Immunization Program of Federally ...... concern not only for health administration in F
Comprehensive multi-year Plan | Immunization Program of Federally Administered Tribal Areas (FATA). 1 ..... Auto-destruc
Vaccines constitute cost-effective measures for preventing ... After the deliberate release of anthrax spores .... Expanded Program on Immunization assumes the ...
oral Sabin polio vaccine because in rare cases the latter caused vaccine-associated paralytic poliomyelitis. Similarly, acellular pertussis vaccine has supplanted ...
the Australian Technical Advisory Group on Immunisation (ATAGI) to ensure that both vaccine manufac- ... [ACT]); and local governments at municipal level within these ..... deliver the potential health service savings and health outcome.
VFC and private stock of a short-dated vaccine dose may be performed if the provider serves a small number of private pa
http://www.sabin.org/programs/sif/downloads/institutions-and-institutional-work?
language=en. 4. ... Anwar Shah (ed): Budgeting and budgetary institutions.
It is important to monitor vaccine-related adverse events because of the role of vaccine safety ... any inappropriate measures based on reports of adverse effect that may cause concern ..... lance system data associated with adverse events after.
Apr 21, 2009 - presented at the 2009 World Vaccine Congress meeting held in the U.S. ... can be accessed at http://www.hhs.gov/nvpo/vacc_plan.) Domestic ...
Aug 26, 2016 - 3 polio vaccine viruses), to bivalent OPV (bOPV; containing types 1 and 3), ... inactivated poliovirus vaccine (IPV) was introduced into India's.
countries: A conversion with Andrew Witty. Health. Aff 2009; 28:411-6. 25. Jain PK. Panacea biotec bags award (USD 34.2 million) for pentavalent vaccine, ...
(OR = 2.1; 95 % CI [1.3â3.4] between 12 and 23 months and OR = 2.7; 95 % CI [1.6â4.4] < 12 ..... immunization card, 9 were vaccinated outside of the of-.
www.immunize.org/catg.d/p2067.pdf ⢠Item #P2067 (8/16). Use the vaccine policy statement below as is, or modify it to
cine, food industry and agriculture. Moreover, in T. gondii .... The reaction was terminated by addition of 50 μl of stop solution and the optical ..... 2000;164:2629â34. 37. Germann T, Bongartz M, Dlugonska H, Hess H, Schmitt E, Kolbe L, et al.
serogroups A, C, W, and Y: 1) meningococcal polysaccharide vaccine (MPSV4, Menomune,*. Sanofi Pasteur) ... protection ag
is pleased to announce the publication of the fourth edition of. The Vaccine
Handbook: A Practical Guide for Clinicians. (“The Purple Book”) by Gary S.
Marshall, ...
Apr 6, 2006 - erythrocytic stage of the parasite's life cycle. Several parasite ..... chains that are buried in the AMA1 structure would not be se- lected for in the ...
Apr 6, 2006 - David L. Narum,1* Solabomi A. Ogun,2 Adrian H. Batchelor,3 and ...... Stubbs, J., K. M. Simpson, T. Triglia, D. Plouffe, C. J. Tonkin, M. T..
Mar 10, 2009 - Photograph of (A) a single microneedle coated with influenza vaccine and (B) a five-needle array of microneedles shown with a 26 gauge.
WEIGHTED AVERAGE COST. PER DOSE. BCG - Japan origin. 10. $0.2140. BCG - India origin. 10. $0.1150. DPT. 10. $0.1600. DPT
EXPANDED PROGRAM OF IMMUNIZATION VACCINE PRICES FOR YEAR 2012 - AMENDMENT II
BCG - Japan origin
Doses per Vial 10
WEIGHTED AVERAGE COST PER DOSE $0.2140
BCG - India origin
10
$0.1150
DPT
10
$0.1600
DPT Hib Lyophilized
1
$2.6500
DPT Hib Líquid
10
$3.3500
DT (Adult)
10
$0.0850
DT (Pediátric)
10
$0.0850
DTaP Triple Acellular Adolescent/Adult
1
$8.5000
DTaP Triple Acellular Pediatric
1
$10.5000
Hepatitis "A" Adult
1
$11.0000
Hepatitis "A" Pediátric
1
$7.1000
Hepatitis B Recombinant Pediatric
1
$0.2400
Hepatitis B Recombinant Adult
1
$0.3650
Hepatitis B Recombinante Adult
10
$0.1950
Human Papilloma Virus (HPV) - Bivalent
1
$13.4800
1
$14.2500
1
$2.5000
1
$5.3000
10
$3.0000
10
$3.3000
10
$3.7000
20
$1.8500
Measles-Rubella
1
$1.6500
Measles-Rubella
10
$0.5100
Measles/Mumps (Urabe )/Rubella
1
$3.5000
Measles/Mumps(Zagreb)/Rubella
1
$1.8500
Measles/Mumps(Zagreb)/Rubella
5
$0.8500
Measles/Mumps(Zagreb)/Rubella
10
$0.9200
Meningococcal A+C (Polysaccharide)
10
$1.5000
Meningococcal C Conjugated
1
$19.5000
Oral Polio (Glass)
10
$0.1650
Oral Polio (Plástic)
10
$0.2500
Oral Polio (Glass)
20
$0.1354
DPT Hep B Hib ( Pentavalent) Lyophilized
1
$2.8800
DPT Hep B Hib ( Pentavalent) Líquid
1
$2.9874
Pneumococcal Conjugated Pediatric - 10 Valent
1
$14.2400
Pneumococcal Conjugated Pediatric - 13 Valent
1
$16.3400
Pneumococcal Unconjugated Adult - 23 valent
1
$6.6000
Pneumococcal Unconjugated Adult - 23 valent
5
$6.4500
Polio Inactivated
1
$5.9848
Rabies Vaccine Human Use/PCEC -Indian Origin
1
$10.5000
Rabies Vaccine Human Use/Vero Cells -French Origin
1
$10.6000
Rotavirus Liquid (2 dose immunization scheme)
1
$6.8800
Rotavirus Liquid (3 dose immunization scheme)
1
$5.2500
Typhoid (Polysaccharide)
20
$7.8000
Varicela
1
$8.3000
Yellow Fever/ Brazil Origin
10
$0.7800
Yellow Fever/France Origin
10
$1.4000
Seasonal Influenza Northern Hemisphere 2012/2013 - Adult - Korea Origin Seasonal Influenza Northern Hemisphere 2012/2013 - Adult - Canada, France and USA Origin Seasonal Influenza Northern Hemisphere 2012/2013 - Pediatric - France and USA Origin
1 10 20
$2.9000 $3.7250 $1.9000
VACCINE
Human Papilloma Virus (HPV) - Quadrivalent Seasonal Influenza Northern Hemisphere 2011/2012 - Adult - Korea Origin
(*)
Seasonal Influenza Northern Hemisphere 2011/2012 - Adult - France Origin Seasonal Influenza Northern Hemisphere 2011/2012 - Adult - UK Origin
Seasonal Influenza Northern Hemisphere 2011/2012 - Adult - France and USA Origin Seasonal Influenza Northern Hemisphere 2011/2012 - Pediatric- France and USA Origin
(*) (*)
(*) Seasonal Flu Vaccine Northern Hemisphere 2011-2012 was used to cover demand of Seasonal Flu Vaccine Southern Hemisphere 2012 due to the fact that it is WHO prequalified and its composition is the same
